Tyson Bio HS100/HS100-B/HS200/HS200-B Blood Glucose Monitoring System。 - Taiwan Registration 34a590e92fe3f183873d96cd8cc3dae4
Access comprehensive regulatory information for Tyson Bio HS100/HS100-B/HS200/HS200-B Blood Glucose Monitoring System。 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 34a590e92fe3f183873d96cd8cc3dae4 and manufactured by TYSON BIORESEARCH INC.. The authorized representative in Taiwan is TYSON BIORESEARCH INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
34a590e92fe3f183873d96cd8cc3dae4
Ministry of Health Medical Device Manufacturing No. 006282
Product Details
This product is intended for in vitro diagnostics, quantitatively measuring fresh microvascular whole blood and venous whole blood from fingertips, palms or forearms, and is not suitable for neonatal diagnosis. It can be used by the general public (single person) and professionals to monitor diabetes.
A Clinical chemistry and clinical toxicology
A1345 Glucose Test System
Produced in Taiwan, China
Dates and Status
Feb 20, 2019
Feb 20, 2029